Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Abazid

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Scientific Reports|January 21, 2025
Non-invasive physical plasma improves conventional wound management of cut and bite wounds in wild European hedgehogsJürgen Eichler, Björn Rulik, Alexander Abazid, et al.
Experimental and Therapeutic Medicine|April 1, 2025
Tissue adhesion after surgical interventions (Review)Malin C K Sturm, Alexander Abazid, Matthias B Stope
Biomedicines|May 27, 2023
Impact of Non-Invasive Physical Plasma on Heat Shock Protein Functionality in Eukaryotic CellsYanqing Wang, Alexander Abazid, Steffen Badendieck, et al.
Anticancer Research|May 31, 2024
Non-invasive Physical Plasma Modulates Macrophage Polarization: A Potential Strategy for Tumor Microenvironment RemodelingYuequn Niu, Sarah Förster, Steffen Badendieck, et al.
Cancers|November 13, 2025
Non-Invasive Physical Plasma as an Oncological Therapy Option: Modulation of Cancer Cell Growth, Motility, and Metabolism Without Induction of Cancer Resistance FactorsYanqing Wang, Benedikt Eggers, Alexander Abazid, et al.
Anticancer Research|June 26, 2024
Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and EnzalutamideJennifer H S Küster, Holger H H Erb, Hannes Ahrend, et al.
Journal of Cellular Biochemistry|July 13, 2019
The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cellsAlexander Abazid, Benedikt Martin, Anja Choinowski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Scientific Reports|January 21, 2025
Non-invasive physical plasma improves conventional wound management of cut and bite wounds in wild European hedgehogsJürgen Eichler, Björn Rulik, Alexander Abazid, et al.
Experimental and Therapeutic Medicine|April 1, 2025
Tissue adhesion after surgical interventions (Review)Malin C K Sturm, Alexander Abazid, Matthias B Stope
Biomedicines|May 27, 2023
Impact of Non-Invasive Physical Plasma on Heat Shock Protein Functionality in Eukaryotic CellsYanqing Wang, Alexander Abazid, Steffen Badendieck, et al.
Anticancer Research|May 31, 2024
Non-invasive Physical Plasma Modulates Macrophage Polarization: A Potential Strategy for Tumor Microenvironment RemodelingYuequn Niu, Sarah Förster, Steffen Badendieck, et al.
Cancers|November 13, 2025
Non-Invasive Physical Plasma as an Oncological Therapy Option: Modulation of Cancer Cell Growth, Motility, and Metabolism Without Induction of Cancer Resistance FactorsYanqing Wang, Benedikt Eggers, Alexander Abazid, et al.
Anticancer Research|June 26, 2024
Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and EnzalutamideJennifer H S Küster, Holger H H Erb, Hannes Ahrend, et al.
Journal of Cellular Biochemistry|July 13, 2019
The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cellsAlexander Abazid, Benedikt Martin, Anja Choinowski, et al.
Pageof 1